Europe PMC
Cure8 research brief
Why This Matters
The study asks whether hospitalized IBD patients have longer QT intervals—information that could affect assessment of arrhythmia risk or monitoring when prescribing QT-prolonging drugs.
Who Should Pay Attention
Clinicians (gastroenterologists, hospitalists, cardiologists), researchers studying IBD and cardiac risk, and adult patients with IBD interested in cardiac monitoring.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The study used linked MIMIC-IV and MIMIC-IV-ECG data from 2008–2019 to compare first analyzable ECGs from admissions coded for IBD versus many non-IBD inpatients. The investigators applied propensity-score weighting to balance demographics, heart rate, timing, setting, prior cardiac and kidney disease, and ECG device bandwidth class.
The report is a preprint abstract (structured content depth: abstract); the full methods and results are not included here. That means we can describe the study question and approach but not specific numerical findings or clinical implications.
Keep In Mind
Preprint abstract only and partial extraction: the full paper and peer review are needed before drawing conclusions about causes or clinical action.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationEurope PMC
AuthorsTan Y, Liao L, Huo J +1 more
Study typePreprint
Indexed viaEurope PMC
Source typeResearch paper
PublishedOct 22, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Prevalence and risk factors of pre-neoplastic polyps in patients with ulcerative colits: a cross-sectional retrospective study.
Preneoplastic (adenomatous and serrated) polyps can be precursors to colorectal cancer, so knowing how common they are and what raises risk may affect surveillance planning for people with ulcerative colitis.
Imaging Updates in Inflammatory Bowel Disease.
MRE is a widely used, noninvasive test that increasingly helps characterize disease phenotype and prognosis in Crohn's disease and IBD, which can affect monitoring and treatment planning.
Evaluating objective nutritional biomarkers for the prediction of sarcopenia in Crohn's disease: development and internal validation of a clinical nomogram.
Sarcopenia is common in Crohn's disease and is linked to worse outcomes; a simple GNRI-based prediction tool could help identify at-risk patients without routine CT scanning.